Ftse Mib
33.762,25
-0,83%
DAX
18.720,01
-1,47%
S&P 500
5.702,55
-0,19%
NASDAQ
17.948,32
-0,36%
Bitcoin
62.596,81
-1,23%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Teva Pharmaceutical Industries Ltd (TEVA) Teva Pharmaceutical Industries Ltd (TEVA) Notizie

Teva Pharmaceutical Industries Ltd

TEVA
17,52
-0,24 (-1,35%)
21 Set 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
21/9/202410:15GLOBETeva Presents New Phase 3 Efficacy, Safety and Tolerability..
21/9/202410:10GLOBENew Data Provide Treatment Insights into Options for..
11/9/202422:30GLOBETeva to Present at the Bank of America 2024 Global..
11/9/202412:25IHMARKETNEWSGameStop plunges 11% on stock offering, DJT drops..
04/9/202413:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202423:00GLOBETeva to Present at the Morgan Stanley 22nd Annual Global..
14/8/202413:06EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
13/8/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202421:59EDGAR2Form 144 - Report of proposed sale of securities
31/7/202422:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/7/202413:00EDGAR2Form 8-K - Current report
31/7/202413:00GLOBETeva Announces Strong Growth in Second Quarter Revenues..
31/7/202412:01IHMARKETNEWSUS Index Futures Up Ahead of Fed Decision; Oil Prices Surge..
25/7/202407:30BWTeva and Sanofi Announce Accelerated Timeline for Anti-TL1A..
18/7/202414:30BWTeva Announces First Phase 3 Evidence of Efficacy and Safety..
03/7/202400:00BWTeva to Host Conference Call to Discuss Second Quarter 2024..
29/6/202400:34BWLes nouvelles données portant sur AJOVY® (fremanezumab) dans..
28/6/202421:41BWNeue Daten zu AJOVY® (Fremanezumab) zur Migräneprävention..
28/6/202417:30BWNew AJOVY® (fremanezumab) Migraine Prevention Data..
25/6/202414:00BWTeva Reaches Agreement With the Israel Tax Authority to..
24/6/202415:50BWTeva Announces Launch of Authorized Generic of Victoza®..
17/6/202414:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202414:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202413:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202413:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202413:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202413:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202413:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202413:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202413:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202413:21IHMARKETNEWSAdobe Soars 15% Pre-Market; Visa and Mastercard Encounter..
04/6/202422:05BWTeva to Present at the Goldman Sachs 45th Annual Global..
01/6/202420:25BWNew Data Provide Schizophrenia Treatment Insights into..
01/6/202420:20BWTeva Presents First Real-World Data from the IMPACT-TD..
30/5/202400:38BWTeva Announces AUSTEDO® XR (deutetrabenazine)..
21/5/202402:25BWTeva and Alvotech Announce SIMLANDI® (adalimumab-ryvk)..
15/5/202414:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202414:30EDGAR2Form 8-K - Current report
15/5/202414:15BWTeva Announces Appointment of Matthew Shields to Executive..
09/5/202413:53IHMARKETNEWSBain Capital in Talks to Acquire PowerSchool; Blackstone..
08/5/202413:00BWTeva Reports First Quarter 2024 Financial Results and..
08/5/202412:30BWTeva and Medincell Announce Positive Phase 3 Efficacy..
03/5/202400:30BWTeva to Present at the 2024 Bank of America Healthcare..
02/5/202414:30BWTeva’s 2023 Healthy Future Report Showcases Renewed..
30/4/202410:00GLOBEU.S. Commercialization Agreement with Quallent to Drive..
16/4/202423:43BWAlvotech and Teva Announce U.S. FDA Approval of SELARSDI™..
16/4/202423:30GLOBEAlvotech and Teva Announce U.S. FDA Approval of SELARSDI™..
16/4/202414:00BWTeva’s New Real-World Evidence Presented at the 2024 AAN..
Apertura: 17,67 Min: 17,3401 Max: 17,78
Chiusura: 17,76

La tua Cronologia

NYSE
TEVA
Teva Pharmaceutical Indu...
LSE
RHMP
Round Hill Music Royalty
BIT
F18010
Vontobel Financial Produ...
BIT
UB26FH
UniCredit Bank
NASDAQ
AAWUJXX
Hsbc Bank Usa Na Point t...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network